TGF-beta and kynurenines as the key to infectious tolerance
- PMID: 19162548
- DOI: 10.1016/j.molmed.2008.11.006
TGF-beta and kynurenines as the key to infectious tolerance
Abstract
The maintenance of self-tolerance is an integral part of the immune surveillance process, in which cytokines act as master regulators of a complex network involving multiple cell types. On such cytokines, transforming growth factor-beta (TGF-beta) exerts a suppressive control over immune reactivity, which so far appears to be mostly confined to the T-cell compartment. Recently, dendritic cells (DCs) have been found to be both an early source and a target of TGF-beta actions. In these cells, autocrine, paracrine and T-cell-derived TGF-beta activates the tolerogenic pathway of tryptophan catabolism - mediated by indoleamine 2,3-dioxygenase (IDO) - resulting in a burst of regulatory kynurenines that contribute to establishing a state of 'infectious tolerance'. Current molecular insights suggest a synergistic potential for TGF-beta and IDO in physiologically or therapeutically opposing human pathologies sustained by over-reacting immune responses.
Similar articles
-
Immunosuppression via tryptophan catabolism: the role of kynurenine pathway enzymes.Transplantation. 2007 Jul 15;84(1 Suppl):S17-20. doi: 10.1097/01.tp.0000269199.16209.22. Transplantation. 2007. PMID: 17632406
-
Generation of T cell regulatory activity by plasmacytoid dendritic cells and tryptophan catabolism.Blood Cells Mol Dis. 2008 Jan-Feb;40(1):101-5. doi: 10.1016/j.bcmd.2007.06.026. Epub 2007 Sep 18. Blood Cells Mol Dis. 2008. PMID: 17881253
-
New twists of T cell fate: control of T cell activation and tolerance by TGF-beta and NFAT.Curr Opin Immunol. 2007 Jun;19(3):287-93. doi: 10.1016/j.coi.2007.04.014. Epub 2007 Apr 12. Curr Opin Immunol. 2007. PMID: 17433870 Review.
-
CD3-specific antibody-induced immune tolerance involves transforming growth factor-beta from phagocytes digesting apoptotic T cells.Nat Med. 2008 May;14(5):528-35. doi: 10.1038/nm1749. Epub 2008 Apr 27. Nat Med. 2008. PMID: 18438416
-
Transforming growth factor-beta and the immune response: implications for anticancer therapy.Clin Cancer Res. 2007 Sep 15;13(18 Pt 1):5262-70. doi: 10.1158/1078-0432.CCR-07-1157. Clin Cancer Res. 2007. PMID: 17875754 Review.
Cited by
-
Combinatorial delivery of immunosuppressive factors to dendritic cells using dual-sized microspheres.J Mater Chem B. 2014 May 7;2(17):2562-2574. doi: 10.1039/C3TB21460E. J Mater Chem B. 2014. PMID: 24778809 Free PMC article.
-
Therapy of experimental type 1 diabetes by isolated Sertoli cell xenografts alone.J Exp Med. 2009 Oct 26;206(11):2511-26. doi: 10.1084/jem.20090134. Epub 2009 Oct 12. J Exp Med. 2009. PMID: 19822646 Free PMC article.
-
The kynurenine system and immunoregulation.J Neural Transm (Vienna). 2012 Feb;119(2):197-209. doi: 10.1007/s00702-011-0681-y. Epub 2011 Jul 9. J Neural Transm (Vienna). 2012. PMID: 21744051 Review.
-
Aryl hydrocarbon receptor control of a disease tolerance defence pathway.Nature. 2014 Jul 10;511(7508):184-90. doi: 10.1038/nature13323. Nature. 2014. PMID: 24930766 Free PMC article.
-
Gain‑of‑function of IDO in DCs inhibits T cell immunity by metabolically regulating surface molecules and cytokines.Exp Ther Med. 2023 Apr 3;25(5):234. doi: 10.3892/etm.2023.11933. eCollection 2023 May. Exp Ther Med. 2023. PMID: 37114180 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials